These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11709192)

  • 1. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.
    Clarke PA; te Poele R; Wooster R; Workman P
    Biochem Pharmacol; 2001 Nov; 62(10):1311-36. PubMed ID: 11709192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug target discovery by gene expression analysis: cell cycle genes.
    Walker MG
    Curr Cancer Drug Targets; 2001 May; 1(1):73-83. PubMed ID: 12188893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
    Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
    Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarrays and the gene expression profile of a single cell.
    Kawasaki ES
    Ann N Y Acad Sci; 2004 May; 1020():92-100. PubMed ID: 15208186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA microarrays--perspective of application for drug effectivity and safety evaluation].
    Roman I
    Postepy Biochem; 2008; 54(1):107-15. PubMed ID: 18610588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression microarray technologies in the development of new therapeutic agents.
    Clarke PA; te Poele R; Workman P
    Eur J Cancer; 2004 Nov; 40(17):2560-91. PubMed ID: 15541959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA microarray technology for target identification and validation.
    Jayapal M; Melendez AJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):496-503. PubMed ID: 16700885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategies for therapeutic design in molecular oncology using gene expression profiles.
    Ricci MS; el-Deiry WS
    Curr Opin Mol Ther; 2000 Dec; 2(6):682-90. PubMed ID: 11249746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and clinical biomarkers in drug discovery and development.
    Ross JS; Symmans WF; Pusztai L; Hortobagyi GN
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S29-41. PubMed ID: 16468416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression in cancer: the application of microarrays.
    Macgregor PF
    Expert Rev Mol Diagn; 2003 Mar; 3(2):185-200. PubMed ID: 12647995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of microarray technologies in toxicology research.
    Vrana KE; Freeman WM; Aschner M
    Neurotoxicology; 2003 Jun; 24(3):321-32. PubMed ID: 12782098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression genomics and drug development: towards predictive pharmacology.
    Liu ET
    Brief Funct Genomic Proteomic; 2005 Feb; 3(4):303-21. PubMed ID: 15814022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
    Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
    BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarrays as cancer keys: an array of possibilities.
    Mohr S; Leikauf GD; Keith G; Rihn BH
    J Clin Oncol; 2002 Jul; 20(14):3165-75. PubMed ID: 12118031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DualChip microarray as a new tool in cancer research.
    Gillet JP; de Longueville F; Remacle J
    Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of transcriptional profiling in antibiotics discovery and development.
    Fischer HP; Freiberg C
    Prog Drug Res; 2007; 64():21, 23-47. PubMed ID: 17195470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.